Study of Atezolizumab + Bevacizumab in Patients With Advanced Non-Clear Cell Renal Cell Carcinoma

NCT02724878 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

65

Enrollment

OTHER

Sponsor class

Conditions

Advanced Non-Clear Cell Kidney Cancer

Interventions

DRUG: Bevacizumab
DRUG: Atezolizumab

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]